miR-146a is differentially expressed by myeloid dendritic cell subsets and desensitizes cells to TLR2-dependent activation

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 4955-4965

  Jurkin, Jennifer ^a   Schichl, Yvonne M ^b   Koeffel, Rene ^a   Bauer, Thomas ^a   Richter, Susanne ^a   Konradi, Sabine ^a   Gesslbauer, Bernhard ^a   Strobl, Herbert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; MIRN146 MICRORNA, HUMAN; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; TGFB1 PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPIDERMIS CELL; GENE EXPRESSION; GENE SILENCING; GRANULOCYTE; HUMAN; HUMAN CELL; LANGERHANS CELL; MICROARRAY ANALYSIS; MICROENVIRONMENT; MONOCYTE; MYELOID DENDRITIC CELL; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BACTERIAL INFECTION; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; CELL LINE; CELL STRAIN U937; COMPARATIVE STUDY; DENDRITIC CELL; DESENSITIZATION; DOWN REGULATION; DRUG ANTAGONISM; EPIDERMIS; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MICROBIOLOGY; PHYSIOLOGY;

BACTERIAL INFECTIONS; CELL LINE; CELLS, CULTURED; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; DOWN-REGULATION; EPIDERMIS; HUMANS; MICRORNAS; MYELOID CELLS; PROTO-ONCOGENE PROTEINS; TOLL-LIKE RECEPTOR 2; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA1; U937 CELLS;

EID: 77954488963     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903021     Document Type: Article

References (58)

1. Ueno, H., E. Klechevsky, R. Morita, C. Aspord, T. Cao, T. Matsui, T. Di Pucchio, J. Connolly, J.W. Fay, V. Pascual, et al. 2007. Dendritic cell subsets in health and disease. Immunol. Rev. 219: 118-142.
2. Merad, M., F. Ginhoux, and M. Collin. 2008. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol. 8: 935-947.
3. Zaba, L. C., J. G. Krueger, and M. A. Lowes. 2009. Resident and "inflammatory" dendritic cells in human skin. J. Invest. Dermatol. 129: 302-308.
4. Merad, M., and M. G. Manz. 2009. Dendritic cell homeostasis. Blood 113: 3418-3427.
5. Auffray, C., M. H. Sieweke, and F. Geissmann. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27: 669-692.
6. Baltimore, D., M. P. Boldin, R. M. O'Connell, D. S. Rao, and K. D. Taganov. 2008. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9: 839-845.
7. Xiao, C., and K. Rajewsky. 2009. MicroRNA control in the immune system: basic principles. Cell 136: 26-36.
8. Fazi, F., A. Rosa, A. Fatica, V. Gelmetti,M. L. DeMarchis, C.Nervi, and I. Bozzoni. 2005. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123: 819-831. (Pubitemid 41721029)
9. Rosa, A., M. Ballarino, A. Sorrentino, O. Sthandier, F. G. De Angelis, M. Marchioni, B. Masella, A. Guarini, A. Fatica, C. Peschle, and I. Bozzoni. 2007. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. USA 104: 19849-19854.
10. Lu, J., S. Guo, B. L. Ebert, H. Zhang, X. Peng, J. Bosco, J. Pretz, R. Schlanger, J. Y. Wang, R. H. Mak, et al. 2008. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev. Cell 14: 843-853.
11. Rodriguez, A., E. Vigorito, S. Clare, M. V. Warren, P. Couttet, D. R. Soond, S. van Dongen, R. J. Grocock, P. P. Das, E. A. Miska, et al. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611. (Pubitemid 46683148)
12. Thai, T. H., D. P. Calado, S. Casola, K. M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J. L. Kutok, et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
13. Vigorito, E., K. L. Perks, C. Abreu-Goodger, S. Bunting, Z. Xiang, S. Kohlhaas, P. P. Das, E. A. Miska, A. Rodriguez, A. Bradley, et al. 2007. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27: 847-859. (Pubitemid 350258623)
14. Dorsett, Y., K. M. McBride, M. Jankovic, A. Gazumyan, T. H. Thai, D. F. Robbiani, M. Di Virgilio, B. R. San-Martin G. Heidkamp, T. A. Schwickert, et al. 2008. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28: 630-638.
15. Teng, G., P. Hakimpour, P. Landgraf, A. Rice, T. Tuschl, R. Casellas, and F. N. Papavasiliou. 2008. MicroRNA-155 is a negative regulator of activationinduced cytidine deaminase. Immunity 28: 621-629.
16. Kohlhaas, S., O. A. Garden, C. Scudamore, M. Turner, K. Okkenhaug, and E. Vigorito. 2009. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J. Immunol. 182: 2578-2582.
17. Li, Q. J., J. Chau, P. J. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Skare, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
18. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innateimmune responses. Proc. Natl.Acad. Sci.USA103: 12481-12486.
19. Motsch, N., T. Pfuhl, J. Mrazek, S. Barth, and F. A. Grässer. 2007. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol. 4: 131-137. (Pubitemid 351237914)
20. Cameron, J. E., Q. Yin, C. Fewell, M. Lacey, J. McBride, X. Wang, Z. Lin, B. C. Schaefer, and E. K. Flemington. 2008. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J. Virol. 82: 1946-1958.
21. Dai, R., R. A. Phillips, Y. Zhang, D. Khan, O. Crasta, and S. A. Ahmed. 2008. Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 112: 4591-4597.
22. Pichler, K., G. Schneider, and R. Grassmann. 2008. MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology 5: 100.
23. Starczynowski, D. T., F. Kuchenbauer, B. Argiropoulos, S. Sung, R. Morin, A. Muranyi, M. Hirst, D. Hogge, M. Marra, R. A. Wells, et al. 2010. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat. Med. 16: 49-58.
24. Nahid, M. A., K. M. Pauley, M. Satoh, and E. K. Chan. 2009. miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J. Biol. Chem. 284: 34590-34599.
25. Hou, J., P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang, and X. Cao. 2009. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183: 2150-2158.
26. Hashimi, S. T., J. A. Fulcher, M. H. Chang, L. Gov, S. Wang, and B. Lee. 2009. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 114: 404-414.
27. Lu, L. F., T. H. Thai, D. P. Calado, A. Chaudhry, M. Kubo, K. Tanaka, G. B. Loeb, H. Lee, A. Yoshimura, K. Rajewsky, and A. Y. Rudensky. 2009. Foxp3-dependent microRNA 155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30: 80-91.
28. Martinez-Nunez, R. T., F. Louafi, P. S. Friedmann, and T. Sanchez-Elsner. 2009. MicroRNA-155 modulates pathogen binding ability of Dendritic Cells by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem. 284: 16334-16342.
29. Ratzinger, G., J. Baggers, M. A. de Cos, J. Yuan, T. Dao, J. L. Reagan, C. Münz, G. Heller, and J. W. Young. 2004. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. J. Immunol. 173: 2780-2791.
30. Wollenberg, A., M. Mommaas, T. Oppel, E. M. Schottdorf, S. Günther, and M. Moderer. 2002. Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J. Invest. Dermatol. 118: 327-334.
31. Riedl, E., J. Stöckl, O. Majdic, C. Scheinecker, K. Rappersberger, W. Knapp, and H. Strobl. 2000. Functional involvement of E-cadherin in TGF-beta 1-induced cell cluster formation of in vitro developing human Langerhans-type dendritic cells. J. Immunol. 165: 1381-1386.
32. Strobl, H., E. Riedl, C. Scheinecker, C. Bello-Fernandez, W. F. Pickl, K. Rappersberger, O. Majdic, and W. Knapp. 1996. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J. Immunol. 157: 1499-1507. (Pubitemid 126449086)
33. Steinman, R. M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449: 419-426.
34. Taschner, S., C. Koesters, B. Platzer, A. Jörgl, W. Ellmeier, T. Benesch, and H. Strobl. 2007. Down-regulation of RXRalpha expression is essential for neutrophil development from granulocyte/monocyte progenitors. Blood 109: 971-979.
35. Santegoets, S. J., S. Gibbs, K. Kroeze, R. van de Ven, R. J. Scheper, C. A. Borrebaeck, T. D. de Gruijl, and M. Lindstedt. 2008. Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J. Leukoc. Biol. 84: 143-151.
36. Platzer, B., S. Richter, D. Kneidinger, D. Waltenberger, M. Woisetschläger, and H. Strobl. 2009. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J. Immunol. 183: 66-74.
37. Strobl, H., C. Bello-Fernandez, E. Riedl, W. F. Pickl, O. Majdic, S. D. Lyman, and W. Knapp. 1997. flt3 ligand in cooperation with transforming growth factorbeta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 90: 1425-1434.
38. Gatti, E.,M.A.Velleca,B.C.Biedermann,W.Ma, J. Unternaehrer,M.W. Ebersold, R. Medzhitov, J. S. Pober, and I. Mellman. 2000. Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factormobilized CD34+ progenitors. J. Immunol. 164: 3600-3607.
39. Jörgl, A., B. Platzer, S. Taschner, L. X. Heinz, B. Höcher, P. M. Reisner, F. Göbel, and H. Strobl. 2007. Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the down-stream effector RelB. Blood 109: 185-193.
40. Heinz, L. X., B. Platzer, P. M. Reisner, A. Jörgl, S. Taschner, F. Göbel, and H. Strobl. 2006. Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment. Blood 107: 1445-1453.
41. Platzer, B., A. Jörgl, S. Taschner, B. Höcher, and H. Strobl. 2004. RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 104: 3655-3663.
42. Flo, T. H., O. Halaas, S. Torp, L. Ryan, E. Lien, B. Dybdahl, A. Sundan, and T. Espevik. 2001. Differential expression of Toll-like receptor 2 in human cells. J. Leukoc. Biol. 69: 474-481.
43. Iwama, A., M. Osawa, R. Hirasawa, N. Uchiyama, S. Kaneko, M. Onodera, K. Shibuya, A. Shibuya, C. Vinson, D. G. Tenen, and H. Nakauchi. 2002. Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment. J. Exp. Med. 195: 547-558.
44. Borkowski, T. A., J. J. Letterio, A. G. Farr, and M. C. Udey. 1996. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184: 2417-2422.
45. Kaplan, D. H., M. O. Li, M. C. Jenison, W. D. Shlomchik, R. A. Flavell, and M. J. Shlomchik. 2007. Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J. Exp. Med. 204: 2545-2552.
46. Reddy, V. A., A. Iwama, G. Iotzova, M. Schulz, A. Elsasser, R. K. Vangala, D. G. Tenen, W. Hiddemann, and G. Behre. 2002. Granulocyte inducer C/EB-Palpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions. Blood 100: 483-490.
47. Kobayashi, T., P. T. Walsh, M. C. Walsh, K. M. Speirs, E. Chiffoleau, C. G. King, W. W. Hancock, J. H. Caamano, C. A. Hunter, P. Scott, et al. 2003. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 19: 353-363.
48. Cejas, P. J., L. M. Carlson, D. Kolonias, J. Zhang, I. Lindner, D. D. Billadeau, L. H. Boise, and K. P. Lee. 2005. Regulation of RelB expression during the initiation of dendritic cell differentiation. Mol. Cell. Biol. 25: 7900-7916.
49. Caux, C., C. Massacrier, B. Dubois, J. Valladeau, C. Dezutter-Dambuyant, I. Durand, D. Schmitt, and S. Saeland. 1999. Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J. Leukoc. Biol. 66: 781-791.
50. Geissmann, F., P. Revy, A. Regnault, Y. Lepelletier, M. Dy, N. Brousse, S. Amigorena, O. Hermine, and A. Durandy. 1999. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162: 4567-4575.
51. Ohtani, T., M. Mizuashi, S. Nakagawa, Y. Sasaki, T. Fujimura, R. Okuyama, and S. Aiba. 2009. TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation. Immunology 126: 485-499.
52. Ebert, M. S., J. R. Neilson, and P. A. Sharp. 2007. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4: 721-726.
53. Flacher, V., M. Bouschbacher, E. Verronèse, C. Massacrier, V. Sisirak, O. Berthier-Vergnes, B. de Saint-Vis, C. Caux, C. Dezutter-Dambuyant, S. Lebecque, and J. Valladeau. 2006. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J. Immunol. 177: 7959-7967.
54. Rozis, G., A. Benlahrech, S. Duraisingham, F. Gotch, and S. Patterson. 2008. Human Langerhans' cells and dermal-type dendritic cells generated from CD34 stem cells express different toll-like receptors and secrete different cytokines in response to toll-like receptor ligands. Immunology 124: 329-338.
55. Riedl, E., J. Stöckl, O. Majdic, C. Scheinecker, W. Knapp, and H. Strobl. 2000. Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood 96: 4276-4284.
56. Jiang, A., O. Bloom, S. Ono, W. Cui, J. Unternaehrer, S. Jiang, J. A. Whitney, J. Connolly, J. Banchereau, and I. Mellman. 2007. Disruption of E-cadherinmediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27: 610-624.
57. Klechevsky, E., R. Morita, M. Liu, Y. Cao, S. Coquery, L. Thompson-Snipes, F. Briere, D. Chaussabel, G. Zurawski, A. K. Palucka, et al. 2008. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29: 497-510.
58. Stenvang, J., M. Lindow, and S. Kauppinen. 2008. Targeting of microRNAs for therapeutics. Biochem. Soc. Trans. 36: 1197-1200.